European Medicines Agency (EMA) | What's new Follow Human medicines European public assessment report (EPAR): Rapiscan, regadenoson, Date of authorisation: 06/09/2010, Revision: 16, Status: Authorised https://www.ema.europa.eu/en/medicines/human/EPAR/rapiscan ema.europa.eu
